Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
4
×
life sciences
national blog main
new york blog main
boston blog main
boston top stories
drugs
national top stories
new york top stories
san diego blog main
san diego top stories
amgen
biotech
fda
new york
san francisco blog main
san francisco top stories
achaogen
adams street partners
akcea therapeutics
alder biopharmaceutical
allergan
american academy of neurology
antibiotics
anylam pharmaceuticals
atogepant
beta lactamase inhibitor
biohaven
biomedical advanced research and development authority (barda)
bob azelby
botox
boulder/denver blog main
boulder/denver top stories
brian abrahams
calcitonin gene-related peptide
cardiomyopathy
cholesterol
data
deals
detroit blog main
What
drug
4
×
year
4
×
medicines
big
disease
fda
aces
ago
akcea
alnylam
amyloidosis
announced
approval
approved
arguments
attr
available
bacteria
battle
biopharma
business
ceo
cholesterol
class
commercialized
companies
company
competitors
debilitating
decades
drugs
exited
fighting
flexible
genetic
inclisiran
infections
infectious
key
launches
Language
unset
Current search:
drug
×
year
×
" clinical trials "
×
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
4 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections